InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Conway Kevin John. Officer active across 1 company, notably Generation Bio Co.. Aggregated, 5 disclosures have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Conway Kevin John is a declarant linked to Generation Bio Co., where he is Chief Financial Officer. The record shows 4 filings in total, and the 4 sampled filings run from 2025-01-17 to 2025-10-17, with the transaction nature listed as option exercise. No buy or sell amount is provided in the data.